How can teams compare competing drug programs at the molecule level? This RAS-inhibitor case study shows how AI-powered LCA and SAR turn patents into prioritized leads, structural insight and traceable competitive intelligence.
Browsing: SAR Analysis
Patent R&D Parp7 Inhibitor SAR Workflow Tool Guide What Does WO2025139240A1 Disclose About Parp7 Inhibitor—and…
Patent R&D Heteroaryl-Linked Analogs As Mglu5 Negative Allosteric… SAR Workflow Tool Guide What Does WO2023043833A1…
Patent R&D Bicyclooctane Kras Inhibitors SAR Workflow Tool Guide What Does WO2025129002A1 Disclose About Bicyclooctane…
Patent R&D Quinolone Bcl6 Bifunctional Degraders SAR Workflow Tool Guide What Does WO2023244918A1 Disclose About…
Patent R&D Sulfamide Ribonucleotide Reductase (Rnr) Inhibitors SAR Workflow Tool Guide What Does WO2023043938A1 Disclose…
Patent R&D Sars-Cov2 Main Protease Inhibitors SAR Workflow Tool Guide What Does WO2025171130A1 Disclose About…
Patent R&D Pyrazoloether Analogs As Mglu5 Negative Allosteric… SAR Workflow Tool Guide What Does WO2024059207A2…
Patent R&D Macrocyclic Leucine-Rich Repeat Kinase 2 (Lrrk2)… SAR Workflow Tool Guide What Does WO2024056775A1…
Patent R&D Sortilin Modulators SAR Workflow Tool Guide What Does WO2024047227A1 Disclose About Sortilin Modulators—and…